Abivax
Jump to navigation
Jump to search
Abivax
Abivax (pronounced: /æbɪvæks/) is a clinical-stage biotechnology company focused on harnessing the body's natural immune system to treat diseases with high unmet medical needs.
Etymology
The name "Abivax" is derived from the Latin words "Ab" meaning "from" and "Vax" short for "vaccine", indicating the company's focus on developing vaccines from the body's immune system.
Related Terms
- Biotechnology: The use of living systems and organisms to develop or make products.
- Clinical-stage: A stage in the clinical research process that helps determine if a new treatment could work on people and if it is safe.
- Immune system: The body's defense against infectious organisms and other invaders.
- Vaccine: A biological preparation that provides active acquired immunity to a particular infectious disease.
See Also
External links
- Medical encyclopedia article on Abivax
- Wikipedia's article - Abivax
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski